MTHFR C677T is not a risk factor for autism spectrum disorders in South Brazil

Psychiatr Genet. 2010 Aug;20(4):187-9. doi: 10.1097/YPG.0b013e32833a2220.

Abstract

Many studies have suggested that autism may be associated with metabolic abnormalities in the folate/homocysteine pathway, which is involved in DNA methylation, thus altering gene expression. One of the most important polymorphisms in this pathway is C677T of the methylenetetrahydrofolate reductase gene, because the T allele is associated with a decrease in enzymatic activity. We evaluated the association between C677T polymorphism and autism spectrum disorders through a case--control study. In addition, we analyzed the influence of this polymorphism on certain autistic behaviors like complex body movements, self-injury and averted gaze according to the Autism Diagnostic Interview-Revised. The analyses involved 151 children with idiopathic autism spectrum disorder and 100 healthy control children. The frequency of the T allele was 0.38 for the case group and 0.35 for the control group (P=0.77). The genotypic distribution did not show significant differences between cases and controls (P=0.72), nor association between the T allele and selected behaviors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autistic Disorder / enzymology*
  • Autistic Disorder / genetics*
  • Brazil
  • Case-Control Studies
  • Child
  • Female
  • Gene Frequency / genetics
  • Genetic Predisposition to Disease*
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Polymorphism, Single Nucleotide / genetics*
  • Risk Factors

Substances

  • Methylenetetrahydrofolate Reductase (NADPH2)